USPTO serial 90471600
RADIANCE
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SULLIVAN, JOHN C
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with RADIANCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,844*
Plus Government fees of $900
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Palo Alto, CA, US
Palo Alto, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SARAH OTTE GRABER
SARAH OTTE GRABER WOOD HERRON & EVANS LLP600 Vine StreetSuite 2800CINCINNATI, OH 45202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments for renal denervation, treating and reducing hypertension, controlling blood pressure, and treating arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction as treated in a medical setting, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; Medical device systems consisting of medical devices for renal denervation, treating and reducing hypertension, controlling blood pressure, and treating arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction as treated in a medical setting, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; ultra-sound-emitting catheters used to perform denervation in human beings; medical devices for treating hypertension, arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction as treated in a medical setting, contrast nephropathy, diabetes, metabolic disorder and insulin resistance; medical devices used to perform denervation; medical device systems consisting of devices used in a medical setting to perform intravascular denervation; Medical device systems for use in renal denervation and other forms of neuromodulation of the autonomic nervous system, consisting of medical devices, catheters, electrical generators, plastic cartridges for medical fluids, connection cables, carts, and remote controls for medical devices for use in performing denervation of human beings; ultrasound renal denervation systems consisting of medical devices for renal denervation; energy emitting catheter-based systems consisting of medical devices and devices for medical procedures in the nature of neuromodulation and denervation of the autonomic nervous system for use in treating a variety of medical conditions, including hypertension, arrhythmia, heart failure, chronic kidney disease, atrial fibrillation, end stage renal disease, myocardial infarction, anxiety as treated in a medical setting, contrast nephropathy, diabetes, metabolic disorder and insulin resistance, and also consisting of catheters, electrical generators, plastic cartridges for medical fluids, connection cables, carts, and remote controls for medical devices used in connection with the preceding systems and devices; medical devices for sensing nerve activity and for performing denervation; Medical devices used in a medical setting to perform intravascular denervation, the foregoing devices are used to lower high blood pressure or treat vascular or cardiovascular conditions and diseases and are not for use in urological procedures; the foregoing medical devices, systems, apparati and instruments are also not for use in and exclude the fields of medical and veterinary ophthalmology, and dermatology | ACTIVE | — |
| 016 | Printed publications, namely, pamphlets, journals, articles, and booklets in the field of healthcare; printed promotional brochures about healthcare excluding the field of urology, medical and veterinary ophthalmology, and dermatology; printed training materials in the field of healthcare excluding the field of urology, medical and veterinary ophthalmology, and dermatology; research reference materials being printed pamphlets, journals, articles, and booklets in the field of healthcare excluding the field of urology, medical and veterinary ophthalmology, and dermatology; patient diary and study and patient participation and clinical trial materials, namely, printed patient questionnaires, patient disclosure forms, letters and brochures; study posters made of paper featuring call center information; printed research reports and peer-reviewed journal articles about healthcare excluding the field of urology, medical and veterinary ophthalmology, and dermatology | ACTIVE | — |
| 035 | Consultation relating to the purchase of medical and surgical equipment, apparatus and appliances and instruments; consultancy services related to medical records coding and business administration of medical reimbursement programs, excluding the fields of medical and veterinary ophthalmology, and dermatology | ACTIVE | — |
| 041 | Education, namely, training in the use and operation of medical and surgical equipment, apparatus and appliances and instruments, and consultation relating to the selection and purchase thereof, and use in medical care, medical therapy and surgery, excluding the field of urology, medical and veterinary ophthalmology, and dermatology | ACTIVE | — |
| 042 | Medical research services; providing an online computer database, namely, a repository of information in the field of healthcare and medical clinical studies, case studies, peerreviewed journal articles and references, excluding the field of urology, medical and veterinary ophthalmology, and dermatology | ACTIVE | — |
| 044 | Providing medical information, consultancy and advisory services; professional consultation in the field of the use of medical and surgical equipment, apparatus, appliance and instruments; consultation on medical care, medical therapy and surgery; consultation services, namely, providing medical information to medical professionals to assist in the diagnosis and treatment of patients; medical consultation with physicians regarding the use of medical apparatus for treatment of patients; technical consultation in the field of medical and surgical equipment, apparatus, appliances and instruments, namely, consultation regarding their use in providing medical care, medical therapy and surgery; providing a patient support program, namely, providing medical information to patients evaluating therapeutic treatment options; providing medical information to patients in the field of surgery preparation; maintaining patient medical records and files in preparation for surgery; providing an on-line computer database, namely, a repository of information in the field of medical information and healthcare information accessible to healthcare providers including clinical studies, case studies, peer reviewed journal articles and references; managed healthcare services, namely, providing disease management programs to others excluding such services in the field of memory care; consultation relating to the use of medical and surgical equipment, apparatus and appliances and instruments in medical care, medical therapy and surgery; excluding the field of urology from all of the foregoing services, and excluding the fields of medical and veterinary ophthalmology, and dermatology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ReCor Medical, Inc.
- Other trademarks owned by ReCor Medical, Inc.
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RADIANCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 16, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 9, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 8, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 14, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 20, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 20, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 20, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 20, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 6, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 6, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 17, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 16, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 18, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 5, 2025 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Feb 5, 2025 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Feb 5, 2025 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jun 9, 2023 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| May 11, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Apr 11, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 11, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 22, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 6, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 6, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 6, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 6, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 22, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 22, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 22, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 2, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 1, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 1, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 1, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 28, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 28, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 28, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 28, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 28, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 17, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 21, 2021 | NWAP | NEW APPLICATION ENTERED | — |